Assembly Biosciences Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 1,545.0% | 513.9% | 410.9% | 319.6% | 407.9% | 554.4% | 445.9% | 568.9% | 584.4% | 607.1% | 513.7% | 465.4% | 564.7% | 59.2% | 77.8% | 2,702.3% | – | – | 295.4% | – | – | – | – | – | – | – | – | 1.2% | 0.6% | 0.4% | 197.4% | 194.1% | 157.7% | 167.5% | 153.7% | 0.1% | 0.3% | 0.1% | 22.3% | |
| – | – | -1,445.0% | -413.9% | -310.9% | -219.6% | -307.9% | -454.4% | -345.9% | -468.9% | -484.4% | -507.1% | -413.7% | -365.4% | -464.7% | 40.8% | 22.2% | -2,602.3% | – | – | -195.4% | – | – | – | – | – | – | – | – | 98.8% | 99.4% | 99.6% | -97.4% | -94.1% | -57.7% | -67.5% | -53.7% | 99.9% | 99.7% | 99.9% | 77.7% | |
| – | – | 1,545.0% | 513.9% | 410.9% | 319.6% | 407.9% | 554.4% | 445.9% | 568.9% | 584.4% | 607.1% | 513.7% | 474.5% | 564.7% | 59.2% | 77.8% | 3,231.3% | – | – | 295.4% | – | – | – | – | – | – | – | – | 153.7% | 205.3% | 190.5% | 197.4% | 194.1% | 157.7% | 167.5% | 153.7% | 40.6% | 181.4% | 111.5% | 85.0% | |
| – | – | 590.4% | 161.1% | 157.2% | 150.8% | 159.8% | 389.8% | 180.9% | 235.8% | 245.0% | 132.5% | 200.6% | 192.5% | 213.9% | 24.1% | 33.8% | 672.3% | – | – | 106.4% | – | – | – | – | – | – | – | – | 121.6% | 80.1% | 52.5% | 62.6% | 62.6% | 47.9% | 47.7% | 47.1% | 12.8% | 57.0% | 35.9% | 26.7% | |
| – | – | 2,135.4% | 675.1% | 568.1% | 470.4% | 567.7% | 944.2% | 626.7% | 804.7% | 829.4% | 739.6% | 714.3% | 236.4% | 213.9% | 24.1% | 33.8% | 1,220.4% | – | – | 106.4% | – | – | – | – | – | – | – | – | 274.0% | 284.9% | 242.6% | 62.6% | 62.6% | 47.9% | 47.7% | 47.1% | 53.4% | 238.4% | 147.3% | 89.6% | |
| – | – | -2,035.4% | -575.1% | -468.1% | -370.4% | -467.7% | -844.2% | -526.7% | -704.7% | -729.4% | -639.6% | -614.3% | -601.8% | -678.6% | 16.7% | -11.6% | -3,822.8% | – | – | -301.8% | – | – | – | – | – | – | – | – | -175.2% | -185.5% | -143.0% | -160.1% | -156.7% | -105.5% | -115.2% | -100.9% | 46.6% | -138.4% | -47.4% | -11.8% | |
| – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | 25.5% | 1.8% | 1.9% | 21.6% | – | – | 1.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -2,035.5% | -579.3% | -462.8% | -360.5% | -455.8% | -834.1% | -502.6% | -669.9% | -696.5% | -601.1% | -591.1% | -552.7% | -653.1% | 18.5% | -9.7% | -3,801.2% | – | – | -300.7% | – | – | – | – | – | – | – | – | -152.6% | -156.9% | -125.9% | -140.4% | -139.4% | -93.6% | -105.9% | -85.2% | 52.0% | -110.5% | -28.8% | -0.1% | |
| – | – | 0.1% | -2.9% | -1.3% | -269.8% | -11.9% | -1.1% | -0.2% | 30.5% | -0.2% | -0.4% | -0.4% | 15.5% | -2.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.5% | -0.2% | 4.8% | – | 1.0% | – | – | – | – | – | – | – | |
| – | – | -2,035.5% | -576.4% | -461.4% | -90.7% | -455.8% | -833.0% | -502.5% | -700.4% | -696.3% | -600.7% | -590.8% | -568.3% | -653.1% | 18.5% | -9.7% | -3,801.2% | – | – | -300.7% | – | – | – | – | – | – | – | – | -153.0% | -156.9% | -130.7% | -140.4% | -140.5% | -93.6% | -105.9% | -85.2% | 52.0% | -110.5% | -28.8% | -0.1% | |
| – | – | -2,030.8% | -572.9% | -466.5% | -367.5% | -462.9% | -829.6% | -523.0% | -700.1% | -725.9% | -597.0% | -611.6% | -555.5% | -675.8% | 17.0% | -11.2% | -3,244.4% | – | – | -298.8% | – | – | – | – | – | – | – | – | -151.4% | -156.4% | -125.6% | -140.0% | -139.0% | -93.3% | -105.6% | -84.9% | 52.1% | -110.2% | -28.7% | 0.1% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.